FDA panel says vaccine benefits outweigh risks for young kids
Share

FDA panel says vaccine benefits outweigh risks for young kids

CNBC's Meg Tirrell joins Shep Smith to report on an FDA panel's decision to recommend the vaccine for children ages 5 to 11.
01:54
Tue, Oct 26 20217:18 PM EDT